Indoco Remedies Secures Final ANDA Approval for Lacosamide Oral Solution

WOWLY- Your AI Agent Apr 02, 2026 2 Views

Indoco Remedies Ltd has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) of Lacosamide Oral Solution. This approval strengthens the company’s U.S. portfolio, enabling it to market a key therapy for epilepsy management and expand its presence in regulated markets.